The First International Pediatric Oncology Congress in memory of the late Prof. Parvaneh Vossough, one of the foremost global authorities in pediatric hematology-oncology and the chairperson of MAHAK Board of Trustees, was held on May 15 – 17 2014 at MAHAK.

 

This congress was held jointly by MAHAK Pediatric Cancer Treatment and Research Center (MPCTRC), Iranian Society of Pediatric Hematology and Oncology (ISPHO) and German Society for Pediatric Oncology and Hematology (GPOH). Several Iranian physicians from all over the country along with 11 leading medical specialists and professors from abroad with the goal of sharing the latest findings and experiences in the field attended this event.

 

The opening ceremony of this three-day congress was held with the presence of prominent figures such as Dr. Hassan Abolghassemi, head of Iranian Pediatric Hemotology-Oncolgy Society, Dr. Ardeshir Ghavamzadeh, Chief of Hematology-Oncology and BMT Research Center of Tehran University of Medical Sciences to name a few.  Dr. Mardawig Alebouyeh, a member of the MAHAK Board of Trustees and the president of the congress was the first speaker officially opening the congress by greeting all attendees, sharing professional memories of Prof. Vossough while explaining the importance of such congresses in the medical community. Afterwards Mr. Arasb Ahmadian, Managing Director of MAHAK, welcomed all attendees followed by a brief presentation of MAHAK and its recent accomplishments.

 

Scientific sessions began after the opening ceremony and continued on with subjects related to MDS, ALL, AML, CML, BMT and pain management for the proceeding two days.

 

MAHAK consistently strives to have a proactive participation in the regional and international fora, conferences, workshops, and congresses which are held in the field of cancer throughout the globe to share knowledge and achievements in the areas of research and treatment of all cancer types affecting children.

 

We express our preparedness and determination to play an active role toward the fruition of our common dream of eradicating cancer and hope that one day all cancer-stricken children receive the global support and assistance required for a life of health, dignity and fulfillment.

 

• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 

• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  The opening ceremony of this three-day congress was held with the presence of prominent figures as follows
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Dr. Hassan Abolghasemi, Head of Iranian Pediatric Hematology-Oncology Society
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Dr. Mohammad Hassan Kariminejad, Head of Kariminejad-Najmabadi Genetic Center
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough
  Dr. Mardawig Alebouyeh, a member of the MAHAK Board of Trustees and the President of the Congress
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough
  Ms. Saideh Ghods, the Founder and Member of Both Boards of Trustees and Directors of MAHAK New Risk Groups in Pediatric AML in Context of Allo-HSCT in CR1
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHA
  Scientific sessions began after the opening ceremony and continued on with subjects related to MDS, ALL, AML, CML for the proceeding two days. List of some key speakers are as follow
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHA
  Prof. Ursula Creutzig, Pediatric Hematology-Oncology Specialist - Hannover Medical School and Honorary Congress President Presentation: AML – de novo; BFM Protocol and Relapse Therapy MDS and JMML New Approach in APL New Risk Groups in Pediatric AML in Context of Allo-HSCT in CR1
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHA
  Prof. Andrea Giovanni Maria Biondi, Pediatric Hematology-Oncology Specialist – University of Milano-Bicocca, Milan, Italy Presentation: Challenges and Perspectives in Clinical Trials of Childhood ALL
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough
  Prof. Theodore Anatole Girinsky, Pediatric Hematology-Oncology Specialist – Institut Gustave Roussy, Villejuif, France Presentation: TBI in Bone Marrow Transplantation Prof. Christine Maria Peters, Pediatric Hematology-Oncology Specialist – St. Anna Children Hospital, Vienna, Austria Presentation: SCT in ALL and AML Patients
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Dr. Azim Mehrvar, Pediatric Hematology-Oncology Specialist - Head of MAHAK Hospital Presentation: Leukemia in MAHAK ‘s CPTRC
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Prof. Odile Marie Faure Oberlin, Pediatric Hematology-Oncology Specialist - Institut Gustave Roussy, Villejuif, France Presentation: Late Effects in Cured Cancer Patients and Necessity for Long Term Follow-Up
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Prof. Dirk Reinhardt, Pediatric Hematology-Oncology Specialist - Hannover Medical School, Hannover, Germany Presentation: Therapy in DS Targeted Therapy
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough
  Prof. Ravindranath Yaddanapudi, Pediatric Hematology-Oncology Specialist – Michigan Children Hospital, Detroit, Michigan
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough
  Prof. Monika Maria Fuhrer, Pediatric Hematology-Oncology Specialist – Munich University Children Hospital, Munich, Germany Presentation: Palliative and Pain Therapy
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Prof. Rita Beier, Pediatric Hematology Oncology Specialist - Member of the Commission Clinical studies of MHH - Hannover Medical School, Hannover, Germany Presentation: Challenges and Perspectives in Clinical Trials of Childhood ALL ALL Treatment, BFM Protocol
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough in MAHAK
  Prof. Meinolf Suttorp, Pediatric Hematology-Oncology Specialist – Dresden University Children Hospital, Dresden, Germany Presentation: CML Diagnosis and Treatment (Sct or Dasatinib therapy) ALL Relapse
• 1st International Pediatric Congress in Memory of the late Prof. Parvaneh Vossough
  Prof. Jacqueline Cloos, Pediatric Hematology-Oncology Specialist – VU University Medical Center, Amsterdam, Netherlands Presentation: Molecular Diagnosis and New Diagnostic Methods in ALL and AML

• 
• 
• 

• 
• 
• 

• 
• 
• 

• 
• 
• 

• 
• 
• 

• 
•